Browse our list of all drugs used for aches and pains.

Lists Of

List of All Drugs

There are literally thousands of drugs available to Americans for aches and pains as well as for more serious illnesses. Some drugs are approved by the FDA for use and others are homeopathic in nature. Many prescription drugs today are abused and a drug treatment program is needed. Most doctors agree that the best course to take is to use FDA approved drugs. If you live in Canada there is a seperate list of Canadian drugs which is different from this list.

Below you will find a list of all drugs approved by the FDA since 1995.

Angiomax (bivalirudin); For patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA); Medicines Company; Approved December 2000

Argatroban Injection; Anticoagulant for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia.; Texas Biotechnology Corporation, SmithKline Beecham; Approved June 2000

Atacand HCT; For the treatment of hypertension; AstraZeneca; Approved September 2000

Betapace AF Tablet; For treatment of the irregular heartbeats in patients with atrial fibrillation; Berlex Laboratories; Approved February 2000

Diltiazem HCL, Extended-Release Capsules; For the reduction of high blood pressure; Biovail Laboratories; Approved January 2000

Innohep (tinzaparin sodium) injectable; For the treatment of acute symptomatic deep vein thrombosis; Dupont Pharmaceuticals; Approved July 2000

Lescol XL (fluvastatin sodium) tablet, extended release; For the use as an adjunct to diet to reduce elevated total cholesterol; Novartis; Approved October 2000

Micardis (hydrochlorothiazide; telmisartan) Tablet; For the treatment of hypertension; Boehringer Ingelheim; Approved November 2000

Nitrostat (nitroglycerin) Tablets; For the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.; Parke-Davis; Approved May 2000

Altocor (lovastatin) Extended-Release Tablets; Oral tablets for the adjuctive treatment of hypercholesterolemia; Andrx; Approved June 2002

Benicar; Oral tablet for the treatment of hypertension; Sankyo Pharma; Approved April 2002

Imagent (perflexane lipid microspheres); Ultrasound contrast agent for improved imaging of the heart; Alliance Pharmaceutical; Approved June 2002

Inspra (eplerenone tablets); Oral tablets for the treatment of high blood pressure.; Pharmacia; Approved September 2002

Plavix (clopidogrel bisulfate); For the treatment of acute coronary syndrome; Sanofi-Synthelabo; Approved February 2002

Remodulin (treprostinil); For the treatment of pulmonary arterial hypertension in patients with NYHA Class II-IV symptoms; United Therapeutics; Approved May 2002

Find parenting advice on how to talk to your teens about drugs and more.

BiDil (isosorbide dinitrate/hydralazine hydrochloride); For the treatment of heart failure in black patients; NitroMed; Approved June, 2005

Crestor (rosuvastatin calcium); For the treatment of primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia; AstraZeneca; Approved August 2003

Levitra (vardenafil); For the treatment of erectile dysfunction related to sexual activity in men; Bayer, GlaxoSmithKline; Approved September 2003

Agrylin; Treatment for Thrombocythemia; Roberts Pharmaceutical; Approved December 1998

Atacand; Treatment for hypertension; Astra Merck; Approved June 1998

Atacand (R) (candesartan cilexetil); Treatment for hypertension; Astra Merck; Approved June 1998

CellCept; Treatment for the prevention of organ rejection inpatients undergoing heart transplants; Roche; Approved February 1998

Diovan HCT; Treatment for hypertension; Novartis; Approved March 1998

Integrilin; Injection of eptifibatide; COR Therapeutics, Key Pharmaceuticals; Approved May 1998

Micardis; Treatment for Hypertension; Boehringer Ingelheim; Approved November 1998

Rythmol; Treatment for paroxysmal atrial fibrillation; Knoll Pharmaceutical; Approved January 1998

Tiazac; Treatment for chronic stable angina; Forest Laboratories; Approved February 1998

Tricor; Treatment for very high triglyceride levels; Abbott Laboratories; Approved February 1998

Viagra; Treatment for impotence; Pfizer; Approved March 1998

Captopril and hydrochlorotiazide; Generic equivalent of Capozide; Mylan Laboratories; Approved (tentatively) May 20, 1997

Captopril and hydrochlorotiazide; Treatment for hypertension; Mylan Laboratories; Approved May 1997

Cardizem (R) (Diltiazem HC1 for injection) Monvial (R); Delivery system for Monovial; Hoechst Marion Roussel; Approved September 1997

Corlopam; Treatment for severe high blood pressure; Neurex; Approved September 1997

Diovan; Oral capsules and tablets for the treatment of hypertension; Novartis; Approved January 1997 (capsules); July 2001 (tablets)

DynaCirc CR; Treatment for hypertension; Novartis; Approved February 1997

EDEX; Treatment for erectile dysfunction; Schwarz Pharma; Approved June 1997

Lescol; Treatment for coronary atherosclerosis; Novartis; Approved September 1997

Lexxel (enalapril maleate-felodipine ER); Treatment for hypertension; Astra Merck; Approved January 1997

Microzide (hydrochlorothiazide); Treatment for mild-to moderate hypertension; Watson Pharmaceuticals; Approved January 1997

Normiflo; Treatment for deep venous thrombosis; Wyeth-Ayerst Laboratories; Approved May 1997

Pentoxifylline; Generic equivalent of Trental; Faulding, Mylan Laboratories; Approved July 1997

Pindolol; Generic equivalent of Visken; Teva Pharmaceutical; Approved April 1997

PLAVIX; Treatment for cardiac atherosclerotic events; Sanofi, Bristol-Myers Squibb; Approved November 1997

Posicor; Treatment for hypertension and chronic stable angina pectoris; Roche; Approved June 1997

ReoPro; Treatment for cardiac ischemic complications; Centocor; Approved November 1997

REPRONEX(menotropins for injection, USP); Generic equivalent of Pergonal; Ferring Pharmaceuticals; Approved February 1997

Teveten; Treatment for hypertension; SmithKline Beecham; Approved December 1997

Verapamil; Generic equivalent of Knoll's Isoptin SR and Searle's Calan SR; IVAX; Approved December 1997

Warfarin Sodium tablets; Generic equivalent of Coumadin; Barr Laboratories; Approved March 1997

Zocor; Treatment for high cholesterol; Merck; Approved November 1997

Caduet (amlodipine/atorvastatin ); For the treatment of hypertension, chronic stable angina and vasospastic angina; Pfizer; Approved January 2004

Advicor (extended-release niacin/lovastatin); For the treatment of cholesterol disorders; Kos Pharmaceuticals; Approved December 2001

Natrecor (nesiritide); For the treatment of patients with acutely decompensated congestive heart failure; Scios; Approved August 2001

Teveten HCT (eprosartan mesylate/hydrochlorothiazide); Tablets for the treatment of hypertension; Unimed Pharmaceuticals; Approved November 2001

TriCor (fenofibrate) tablets; For the treatment of primary hypercholesterolemia, mixed lipidemia and hypertriglyceridemia; Abbott Laboratories; Approved September 2001

Lescol (fluvastatin sodium) capsules, Rx; Treatment for the reduction of triglycerides; Novartis; Approved June 1999
Mevacor (lovastatin) tablets; Treatment for primary prevention of coronary heart disease; Merck; Approved March 1999

Niaspan; Niacin extended-release tablets; Kos Pharmaceuticals; October 28, 1999

Androderm (Testosterone Transdermal System); Treatment for primary and secondary hypogonadism; TheraTech; Approved on September 29, 1995

Corvert Injection (ibutilide fumarate injection); Treatment for irregular contractions of the heart; Pharmacia & Upjohn; Approved December 1995

Prinivil or Zestril (Lisinopril); Treatment for hypertension, heart failure, and acute myocardial infarction; Merck, Zeneca; Approved November 24, 1995

Covera-HS (verapamil); Treatment for hypertension and angina; G.D. Searle, Alza; Approved January 1996

Mavik (trandolapril); Treatment for hypertension; Knoll Pharmaceutical; Approved May 1996

Muse; Treatment for impotence; Vivus; Approved October 1996

Pravachol (pravastatin sodium); Treatment for cholesterol-lowering; Bristol-Myers Squibb; Approved July 1996

Pravachol (pravastatin sodium); Treatment for heart disease; Bristol-Myers Squibb; Approved April 1996

ProAmatine (midodrine); Treatment for hypotension; Roberts Pharmaceutical; Approved September 1996

Procanbid (procainamide hydrochloride extended-release tablets); Treatment for ventricular arrhythmias; Warner-Lambert; Approved January 1996

Retavase (reteplase); Treatment for patients suffering from heart attack; Boehringer Mannheim Corporation; Approved November 1996

Teczem (enalapril maleate/diltiazem malate); Treatment for hypertension; Hoechst Marion Roussel; Approved October 1996

Tiazac (diltiazem hydrochloride); Treatment for hypertension; Forest Laboratories; Approved February 1996

Visipaque (iodixanol); Diagnostic contrast agent; Nycomed; Approved April 1996